{"meshTagsMajor":["Gene Expression Regulation, Neoplastic","Germ-Line Mutation","Mutation"],"meshTags":["Adult","Cyclin-Dependent Kinase Inhibitor p16","Family Health","Female","Gene Expression Regulation, Neoplastic","Germ-Line Mutation","Humans","Male","Melanoma","Middle Aged","Mutation","Proto-Oncogene Proteins B-raf","Skin Neoplasms","ras Proteins"],"meshMinor":["Adult","Cyclin-Dependent Kinase Inhibitor p16","Family Health","Female","Humans","Male","Melanoma","Middle Aged","Proto-Oncogene Proteins B-raf","Skin Neoplasms","ras Proteins"],"genes":["NRAS","BRAF","CDKN2A"],"publicationTypes":["Letter","Research Support, Non-U.S. Gov\u0027t"],"title":"Coexisting NRAS and BRAF mutations in primary familial melanomas with specific CDKN2A germline alterations.","pubmedId":"19759551"}